Clinical Trials Browser

Suspended × Sirolimus × Clear all

NCT06876142 2026-04-16

Combination Therapy (Mirdametinib and Sirolimus) for RAS Mutated Relapsed Refractory Multiple Myeloma

Phase 1/2 Suspended

Multiple Myeloma

NCT04177004 2026-04-15

Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant

Phase 1 Suspended

Other hematologic neoplasm

Hematologic Neoplasms